openPR Logo
Press release

Investigation announced for Investors in Bioventus Inc. (NASDAQ: BVS) shares

11-15-2022 05:54 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Bioventus Inc. (NASDAQ: BVS) shares over potential securities laws violations by Bioventus Inc.

An investigation for investors in Bioventus Inc. (NASDAQ: BVS) shares over potential securities laws violations by Bioventus Inc.

An investigation was announced for investors of Bioventus Inc. (NASDAQ: BVS) shares over potential securities laws violations by Bioventus Inc.

Investors who purchased shares of Bioventus Inc. (NASDAQ: BVS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Bioventus Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Durham, NC based Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally.

On February 11, 2021, Bioventus Inc. conducted its initial public offering ("IPO"), selling 8 million shares priced at $13.00 per share.
Bioventus Inc. reported that its annual Total Revenue rose from $321.16 million in 2020 to $430.89 million in 2021, and that its Net Income increased from $16.41 million in 2020 to $19.37 million in 2021.
Since the IPO shares of Bioventus Inc. (NASDAQ: BVS) declined to as low as $2.25 per share on November 9, 2022.

Those who purchased shares of Bioventus Inc. (NASDAQ: BVS) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in Bioventus Inc. (NASDAQ: BVS) shares here

News-ID: 2806597 • Views:

More Releases from Shareholders Foundation

Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to recover losses
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements. Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover losses
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc.. Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Malvern, PA based Ocugen, Inc., a
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) should contact the Shareholders Foundation in connection with Lawsuit
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV
Investigation announced for Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL) over possible Violations of Securities Laws
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false

All 5 Releases


More Releases for Bioventus

Viscosupplementation Market 2021 By Top Players Anika Therapeutics, Inc., Aptiss …
The global viscosupplementation market is anticipated to observe substantial growth due to the increasing instances of osteoarthritis throughout the global geriatric population. Osteoarthritis typically affects the joints in hands, knees, spine, and hips, and is responsible for generating high healthcare costs among its patients. Among these, knee osteoarthritis is the most common type of arthritis, affecting millions of people globally. As per the International Osteoarthritis Foundation reports, more than 300
Orthobiologics Market Swot Analysis by key players Arthrex, Bioventus, Johnson & …
The latest release from HTF MI highlights the key market trends impacting the growth of the Global Orthobiologics market. The study highlights influencing factors that are impacting or reinforcing market environment such as Government Policy, technological changes etc along with key market drivers. The research study forecast Revenue Opportunities and Sales Volume Area taken into consideration the primaries from industry experts and includes relevant data such as (revenue, market Size,
Orthobiologics Market to Witness Highest Growth in Future| Bioventus, Arthrex, S …
Data Bridge Market Research has published a new report titled Global Orthobiologics Market reports provides 5 year pre-historic and forecast for the sector and include data on socio-economic data of global. Key stakeholders can consider statistics, tables & figures mentioned in this report for strategic planning which lead to success of the organization. Some are the key players taken under coverage for this study are Medtronic, NuVasive, Stryker, Zimmer, Orthofix,
2019 Viscosupplementation Market | Anika Therapeutics, Sanofi, Zimmer Biomet, Me …
Viscosupplementation Market report categorizes by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis. Download PDF Sample of this Report @ http://www.supplydemandmarketresearch.com/home/contact/105712?ref=Sample-and-Brochure&toccode=SDMRPH105712&utm_source=S2 The key players covered in this study Anika Therapeutics Sanofi Zimmer Biomet Meda Ferring Fidia Pharmaceutici Bioventus Market size by Product Single
Bone Growth Stimulator Market - Demonstrates Benefits 2025 | Ossatec Benelux BV, …
Global Bone Growth Stimulus Market: Snapshot The Global market for bone growth stimulators has been experiencing a positive transformation for the course of years. Bone growth stimulator is a therapy of supplemental form which works on the potential generated by bones to boost the natural healing process of the body. This is believed to be used as an alternative to bone surgeries to avoid complications and patient’s non-compliance. The rise
Bone Growth Simulator Market Report 2017-Medtronic, Stryker, DePuy Synthes, Arth …
Apex Research, recently published a detailed market research study focused on the "Bone Growth Simulator Market" across the global, regional and country level. The report provides 360° analysis of "Bone Growth Simulator Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Bone Growth Simulator industry, and estimates the future trend of Bone